Aspirin can cut by more than half the risk that colon cancer will come back following initial treatment, a new Karolinska ...
A study involving more than 1,000 cancer patients has found that a low dose of aspirin halves the risk of colorectal tumors ...
1don MSN
Aspirin halves the risk of recurrence in patients with colorectal cancer, clinical trial finds
A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized ...
News-Medical.Net on MSN
Low dose of aspirin cuts recurrence risk in colorectal cancer with genetic mutation
A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical trial that a low dose of the well-known medicine aspirin halves the risk ...
Many U.S. consumers of Hispanic origin grew up with Bayer’s Aspirina, building familiarity over generations. In Mexico, Aspirina maintains a 99 percent awareness rate, with 67 percent of consumers ...
Common drug found to dramatically cut odds of gut cancer return - Findings could have global significance and influence treatment guidelines, researchers say ...
Daily aspirin can cut in half the risk that colon cancer will come back. Risk of recurrence was 55% lower in people who took ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback